NYSEAMERICAN:DXR - Daxor Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $6.11 +0.03 (+0.49 %) (As of 07/20/2018 08:00 AM ET)Previous Close$6.08Today's Range$6.11 - $6.1852-Week Range$3.40 - $21.66Volume2,200 shsAverage Volume307,259 shsMarket Capitalization$20.88 millionP/E RatioN/ADividend Yield0.48%Beta0.33 Company ProfileFinancialsDividend HistoryEarnings HistoryInsider TradesHeadlinesSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York. Receive DXR News and Ratings via Email Sign-up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical SymbolNYSEAMERICAN:DXR CUSIPN/A Webwww.daxor.com Phone+1-212-3308500 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-218.59% Return on Equity-8.02% Return on Assets-5.82% Miscellaneous EmployeesN/A Outstanding Shares3,730,000Market Cap$20.88 Daxor (NYSEAMERICAN:DXR) Frequently Asked Questions What is Daxor's stock symbol? Daxor trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "DXR." How often does Daxor pay dividends? What is the dividend yield for Daxor? Daxor declared a dividend on Thursday, December 28th. Shareholders of record on Monday, January 8th will be given a dividend of $0.03 per share on Friday, January 12th. The ex-dividend date of this dividend is Friday, January 5th. View Daxor's Dividend History. What is the consensus analysts' recommendation for Daxor? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Daxor in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of Daxor's key competitors? Some companies that are related to Daxor include Bovie Medical (BVX), InfuSystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Omega Diagnostics Group (ODX), Relevium Technologies (RLV), Vigil Health Solutions (VGL), Iris Biotechnologies (IRSB), SECTOR 10 (SECI), Lifestyle Delivery Systems (LDSYF) and RESMED/IDR UNRESTR (RMD). Who are Daxor's key executives? Daxor's management team includes the folowing people: Mr. Michael Richard Feldschuh, Chairman, Pres & CEO (Age 49)Mr. Jonathan Adam Feldschuh, Chief Scientific Officer & Director (Age 53)Mr. John Alan Wilkens CPA, Chief Financial OfficerMs. Kathryn A. Kornafel, VP of Marketing & Commercial Devel.Ms. Diane Marie Meegan, Corp. Sec. Has Daxor been receiving favorable news coverage? News coverage about DXR stock has trended somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Daxor earned a news sentiment score of 0.14 on Accern's scale. They also gave headlines about the company an impact score of 45.13 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future. How do I buy shares of Daxor? Shares of DXR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Daxor's stock price today? One share of DXR stock can currently be purchased for approximately $6.11. How big of a company is Daxor? Daxor has a market capitalization of $20.88 million. How can I contact Daxor? Daxor's mailing address is 350 5th Ave Ste 4740, NEW YORK, NY 10118-0002, United States. The company can be reached via phone at +1-212-3308500. MarketBeat Community Rating for Daxor (NYSEAMERICAN DXR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 71 (Vote Outperform)Underperform Votes: 77 (Vote Underperform)Total Votes: 148MarketBeat's community ratings are surveys of what our community members think about Daxor and other stocks. Vote "Outperform" if you believe DXR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: What does earnings per share mean?